Randomized Phase II Study of Weekly Paclitaxel plus Carboplatin Versus Biweekly Paclitaxel plus Carboplatin for Patients with Previously Untreated Advanced Non‐Small Cell Lung Cancer

LESSONS LEARNED. This clinical trial, evaluating the efficacy and safety of a carboplatin plus paclitaxel regimen in a biweekly or weekly schedule instead of the more toxic 3‐weekly administration, showed that the weekly regimen was better in efficacy than the biweekly regimen, with mild toxicities,...

Descripción completa

Detalles Bibliográficos
Autores principales: Takayama, Koichi, Ichiki, Masao, Tokunaga, Shoji, Inoue, Koji, Kawasaki, Masayuki, Uchino, Junji, Nakanishi, Yoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Clinical Trial Results
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853129/
https://www.ncbi.nlm.nih.gov/pubmed/31332099
http://dx.doi.org/10.1634/theoncologist.2019-0513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853129/
https://www.ncbi.nlm.nih.gov/pubmed/31332099
http://dx.doi.org/10.1634/theoncologist.2019-0513

Ejemplares similares